会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • INJECTABLE BIODEGRADABLE PARTICLES FOR CONTROLLED THERAPEUTIC AGENT RELEASE
    • 用于控制性治疗药物释放的可注射的生物可降解颗粒
    • WO2013181022A1
    • 2013-12-05
    • PCT/US2013/042025
    • 2013-05-21
    • BOSTON SCIENTIFIC SCIMED, INC.
    • WEBER, Jan
    • A61L31/14A61L31/16
    • A61K9/146A61L31/06A61L31/16A61L2300/416A61L2400/12A61L2430/36C08L77/12
    • In accordance with one aspect, embolic particles are provided that comprise a biodegradable polymer and a therapeutic agent, wherein the particles are configured such that, upon administration to a body lumen of a subject, the therapeutic agent is released from the time of administration up until a first point in time that ranges anywhere from about 1 week after administration to about 4 weeks after administration, at which point in time the therapeutic agent release ceases. The particles are also configured such that particles remain present in the body lumen from the first point in time at which therapeutic agent release ceases up to a second point in time that ranges anywhere from about 2 weeks to about 12 months after the first point in time, at which point the particles are completely degraded. Other aspects pertain to methods of making such particles. Still other aspects pertain to injectable compositions that comprise such particles and to methods of treatment that employ such injectable compositions.
    • 根据一个方面,提供了包含可生物降解的聚合物和治疗剂的栓塞颗粒,其中所述颗粒构造成使得当给予受试者的体腔时,治疗剂从给药时间开始释放直至 在施用后约1周至给药后约4周的第一时间点,此时治疗剂释放停止。 颗粒还被构造成使得颗粒从治疗剂释放停止的第一时间点保持存在于体腔中,第二时间点在第一时间点之后约2周至约12个月的范围内 ,此时颗粒完全降解。 其他方面涉及制造这种颗粒的方法。 还有其它方面涉及包含这种颗粒的可注射组合物和使用这种可注射组合物的治疗方法。